Given the more pronounced effects observed in the MDA-MB-231 cell line and the possibility that AM infusion enhances membrane permeability—thereby facilitating increased AD uptake—the docking simulation focused on the A2B adenosine receptor, a membrane protein implicated in tumor growth, immune modulation, and chemoresistance [25,26] (Figure 4). Here, ADORA2B is linked to neoplasm.